Gene · 710
NIH grants1,786
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,101 to 1,120 of 1,786
Download this page as JSON| Grant | Title | SERPING1 papers | Newest fiscal year |
|---|---|---|---|
| R01MH077542 | Mechanisms of Neuroinflammation in HAND | 1 | 2016 |
| R01MH105524 | A computational framework for predicting the impact of mutations in autism | 1 | 2016 |
| R01NS077006 | Role of Hyperglycemia in Intracerebral Hemorrhage | 1 | 2016 |
| R03AG050918 | The Significance of Perioperative Changes in CSF tau levels in the Elderly | 1 | 2016 |
| R03AI112808 | Impact of Maternal Obesity on the Neonatal Immune System | 1 | 2016 |
| R03AR066342 | Epigenetic Modulation of the Epiphyseal Growth Plate to Treat Pediatric Limb Deformities | 1 | 2016 |
| R13ES027302 | 2016 SETAC Asia/Pacific Conference | 1 | 2016 |
| R21AI117695 | Targeting factor B to prevent transplant rejection | 1 | 2016 |
| R21AI119821 | Collagen binding as a virulence mechanism in Lyme borreliosis | 1 | 2016 |
| R21MH105853 | Decomposing cell type-specific marks in post-mortem human brain studies | 1 | 2016 |
| R21MH105881 | Long non-coding RNAs in gene regulatory networks underlying Autism | 1 | 2016 |
| R21OD019934 | CRISPR/Cas9 guided production of genetically engineered pigs lacking CD8+ T-cells | 1 | 2016 |
| R35CA197737 | Overcoming resistance to targeted therapy in cancer | 1 | 2016 |
| R37EB000415 | Application of Novel Optical Methods to Cell Dynamics | 1 | 2016 |
| R56AI122813 | Targeting the host kinase DYRK1A to optimize reversal of HIV-1 latency in CD4 T cells | 1 | 2016 |
| R56AI123262 | Accommodation in Transplantation | 1 | 2016 |
| RF1AG054014 | Molecular Characterization and Validation of Gender Differences in Alzheimers Disease Pathogenesis | 1 | 2016 |
| S10OD021619 | Orbitrap Fusion Lumos ETD with IRMPD for UM Chemistry MS Facility Expansion | 1 | 2016 |
| S10OD021805 | High Throughput DNA Sequencer: Illumina HiSeq 3000 Sequencer | 1 | 2016 |
| T32HD071860 | Graduate Training Program in Neonatal-Perinatal Translational Research | 1 | 2016 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/grants?page=56